The 8 Biggest Biotech Medical Fails of 2016 in Europe
Although 2016 has brought plenty of good news in medical advances, biotech is an industry…
Although 2016 has brought plenty of good news in medical advances, biotech is an industry…
Hopes for an Alzheimer’s cure took a hit with Eli Lilly’s recent failure, but it’s…
A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the…
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference…
A Migraine is more than just a headache; it is a neurological disorder affecting a…
What updates have occurred in the Neurodegenerative disease field as of late? New appointments by…
Human insulin produced in Bacteria is already a miracle for Diabetes...but sometimes, it’s not as…
Immunocore Limited, just announced that it has secured a £205 million financing (€293 m) from private…
Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore's lead T cell receptor-based…
Adocia and Eli Lilly completed an impressive Phase Ib clinical trial evaluating BioChaperone Lispro, a…
The big pharma companies Eli Lilly and AstraZeneca will combine two of their cancer drugs…
Using immunotherapy to treat cancer is one of the hottest trends in healthcare research right…